Dimitrios Tzalis holds a PhD from the University of California, San Diego, a M.Sc. in Chemistry from University of Chicago, and a M.Sc. in Biology from Ball State University, Muncie, USA. After a postdoc at the Philips University Marburg, Germany, he founded Taros in 1999, and has since been active as a serial biotech entrepreneur. As a Project Executive and Head of Chemistry, he led the chemistry activities of the EUR 196 million early drug discovery platform „European Lead Factory“ (ELF). Dimitrios is the author of more than 15 publications and holds 4 patents.